Difference between revisions of "Template:SPCaripiprazoleLA"
From Psychiatrienet
| Line 1: | Line 1: | ||
* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref> | * More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref> | ||
| − | * Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg and 960mg preparations. | + | * Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg and 960mg preparations. It is possible to administer a reduced dosage of 300mg and 720mg respectively. |
Revision as of 12:22, 20 February 2025
- More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. [1]
- Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg and 960mg preparations. It is possible to administer a reduced dosage of 300mg and 720mg respectively.
